Browsing Tag
Phase 3 MANEUVER
1 post
Merck advances pimicotinib in China as Center for Drug Evaluation accepts TGCT marketing application following pivotal Phase 3 data
Merck’s TGCT treatment pimicotinib moves closer to approval in China after CDE accepts marketing application; global filings planned next.